Medtronic (NYSE:MDT) Gains FDA Approval for Advanced Insulin Sensor in 2025
Express News | New Simplera Sync™ Sensor for the Minimed™ 780G System Now FDA Approved
New Simplera Sync Sensor for the MiniMed 780G System Now FDA Approved
Press Releases
Medtronic (MDT) Stock Dips While Market Gains: Key Facts
Least Shorted S&P 500 Stocks in March
Short Bets Against S&P 500 Healthcare Stock Rises in March; MRNA Stays Top Shorted
FDA Approves WiSE System, World's First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT
Tariff clouds loom heavy! Barclays names the U.S. stock medical instruments Industry as the 'pressure-resistant king' and the 'hard-hit area'.
Barclays issued a research report analyzing the impact of the new tariff policy of the Trump administration on the medical instruments industry.
Barclays Names Most and Least Affected Healthcare Companies From Tariffs
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
Brave Business Books Releases "Suited for Leadership", A New Book By The President And CEO Of Virtua Health
Medtronic: Rock 'N' Roll Dad's New Music Inspired by Son's Diagnosis
Estimating The Intrinsic Value Of Medtronic Plc (NYSE:MDT)
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating, Cuts Target Price to $90
Medtronic (MDT) Gains But Lags Market: What You Should Know
Medtronic Is Maintained at Hold by Truist Securities
Medtronic Analyst Ratings
Baird Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $94
Baird Adjusts Price Target on Medtronic to $94 From $91, Maintains Neutral Rating